Medication Level Variability During First Year After Pediatric Kidney Transplantation
IPV during the first 3 months was associated with dnDSA development. Both MLVI and IPV during the first 3 months and at the 6- to 12-month interval post-transplant were associated with increased risk of graft failure.
Authors
- Chelsey J. Jensen
- Sarah J. Kizilbash (ORCID: https://orcid.org/0000-0001-5824-7856)
- Danielle M. Glad (ORCID: https://orcid.org/0000-0001-5987-5459)
- Finola Kane‐Grade (ORCID: https://orcid.org/0000-0001-5122-0511)
- Lidan Gu
- Christopher Anzalone
- Michael Evans
Institutions
- Boston Children's Hospital (US)
- University of Minnesota (US)
- Harvard University (US)
- Medical College of Wisconsin (US)
- University of Minnesota Medical Center (US)
- University of Minnesota Children's Hospital (US)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/petr.70278
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00